NL   FR

Randomised Clinical Trial Grant

2023 Wilfried Mullens – ZOL Genk

Renal-based optimization of Quadruple therapy in patients with Heart Failure with reduced ejection fraction (ReQUAD-HF): a prospective, multicentre, international randomised-controlled trial